T. Rowe Price Associates
CCAP icon

T. Rowe Price Associates’s Crescent Capital BDC CCAP Stock Holding History

T. Rowe Price Associates’s Portfolio CCAP Stock Details CCAP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-20,293
Closed -$286K – 3143
2025
Q4 		$286K Sell
20,293
-1,880
-8% -$26.7K ﹤0.01% 2666
2025
Q3 		$317K Buy
+22,173
New +$332K ﹤0.01% 2576

Other funds holding CCAP

TCDRS
Texas County & District Retirement System Austin, Texas $54.6M AUM 22.55% 1-Year Est. Return
FNF
Fidelity National Financial Jacksonville, Florida $3.16B AUM 17.75% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
SLF
Sun Life Financial Toronto, Ontario, Canada $1.95B AUM 25.88% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
AM
Ares Management Los Angeles, California $2.29B AUM 0.27% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $95.2B AUM 32.92% 1-Year Est. Return
BI
Bulldog Investors Saddle Brook, New Jersey $455M AUM 2.3% 1-Year Est. Return
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $417M AUM 22.81% 1-Year Est. Return

T. Rowe Price Associates's CCAP Position: Q1 2026 in Review

T. Rowe Price Associates sold out of Crescent Capital BDC (CCAP) in Q1 2026, closing a stake of 20,293 shares — an estimated $286K sold.

T. Rowe Price Associates first reported a position in CCAP in Q3 2025 and held it in 2 quarters. The position peaked at $317K in Q3 2025. 86 funds tracked by Wall St. Rank hold CCAP as of Q1 2026.

  • T. Rowe Price Associates reported no remaining Crescent Capital BDC position as of Q1 2026 after selling out during the quarter.
  • T. Rowe Price Associates sold 20,293 Crescent Capital BDC shares in Q1 2026, an estimated $286K.
  • T. Rowe Price Associates first reported a position in Crescent Capital BDC in Q3 2025 and held it in 2 quarters.
  • T. Rowe Price Associates's Crescent Capital BDC position peaked at $317K in Q3 2025.
  • 86 funds tracked by Wall St. Rank held Crescent Capital BDC as of Q1 2026.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.